TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Participants Experiencing Unsolicited Adverse Events, by Severity and Relationship to Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number and Percentage of Subjects Experiencing Severe Diarrhea Following H10407 Challenge Strain
Endpoint domain: Adverse events/effects
Primary endpoint: Cutout rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Cognitive Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Amyloidosis Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SARS-CoV-2 related volatile organic compounds (VOC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's early-onset behavior problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased qualities of care parents provide to their children
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Number of Subjects Who Seroconverted for Anti-HPV-16 and Anti-HPV-18 Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Peer conflict
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Relapse within first year of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of Mg as adjuvant to local anesthetic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of sympathetic nervous system activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pathological Complete Response Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of crying/fussing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in glycemic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Initial Onset of Heartburn Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in sleep-diary
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: FEV1 AUC0-12 on Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of GBS colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in diaphragmatic displacement velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Blood pressure level (SBP and DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure compliance rate (SBP and DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improved level of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life, Enjoyment, and Satisfaction Scale (Q-LES-Q)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hamilton Rating Scale for Depression (21-item) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impressions - Improvement Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of MMR
Endpoint domain: Mortality/survival
Primary endpoint: Acne Lesion Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: one month survival
Endpoint domain: Mortality/survival
Primary endpoint: Concentration of pro-inflammatory cytokines and adipokines in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of pro-inflammatory cytokines and adipokines in blood serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Body composition analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of life differences
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk assessment of lower limb atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Corneal Staining Extent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conjunctival Staining Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Palpebral Hyperemia on Upper Lid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of pancreas injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Obsession and Compulsion Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With CNS Metastases as the Site of First Relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Phlebitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with infusion reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Copeptin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Liver elastography results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mullen's Scale of Early Learning (MSEL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum AGE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CB1R availability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported rumination
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: behavioral performance on cognitive tasks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: physiological reactivity to emotional information processing tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Linkage to first outpatient contact
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Radiation Dose (DAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the LROC Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of viral load > 3000 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of cryptic chromosomal imbalance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related Quality of Life (HRQL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Efficacy of topical Vitamin D analogues in reducing acne lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in per- and post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Amplitude of EMG response to sudden arm raising
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latency of EMG response to sudden arm raising
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Center of pressure velocity during sitting balance task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of clinical prediction rules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antithrombotic Effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of Correctly Identified Pre-treatment Photos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Unanticipated Adverse Device Effects (UADE)
Endpoint domain: Adverse events/effects
Primary endpoint: placental settlement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Access to bariatric surgery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Y-BOCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in OCI-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in OBQ-44
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in functional brain circuits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative Pain Score One Hour After Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pain Score Five Days After Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Insulin Concentration (Cmax) - First Phase Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area Under the Insulin Concentration-time Curve (AUC) - First Phase Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximum Insulin Concentration (Cmax) - Second Phase Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Insulin Area Under the Curve (AUC) - Second Phase Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Time to disposition
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Alive Without Intubation or Mechanical Ventilation
Endpoint domain: Mortality/survival
Primary endpoint: Expanded Disability Status Score (EDSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in synovial ectopic lymphoneogenesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Catheter related bloodstream infection
Endpoint domain: Adverse events/effects
Primary endpoint: Average Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of people with asymptomatic CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Evidence of atherosclerosis or calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rate of patients with psycho-cognitive troubles
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Radiocephalic fistula flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal cardiac ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ProBNP, troponin and cystatin levels in cord blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants Who Correctly Select to Use or Correctly De-select Not to Use Ibuprofen 600 mg IR/ER Study Medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in OABSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mean Sitting Diastolic Blood Pressure (msDBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in implant stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of video/workbook contents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Helpfulness of video/workbook contents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants With at Least a 2-Grade Improvement in Facial Redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: ICU free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy Patient Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Moderate or Severe Diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of photodynamic therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Low Anterior Resection Syndrome Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in mental status
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: difference in serum 25OHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intensity of the pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention Strategies
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Behavior
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Acceptability
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Biomarkers of sarcopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of alpha peaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Verbal Learning Task Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Frequency of dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Ocular blood flow (retinal blood flow)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in retinal surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child welfare supervisor ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Immunogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of subjects with symptoms following Q fever vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects with erythema following Q fever vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum observed plasma OPC concentration following a single dose (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC extrapolated to infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants in Sustained Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent days abstinent from alcohol during intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Active cervical range of movement (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ankle stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic lower extremity valgus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extinction Learning Task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Developed Anti-tezepelumab Antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline of the individually corrected QT interval (therapeutic dose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline of the individually corrected QT interval (supra-therapeutic dose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Respiratory-Related Non-Elective Hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of Participants With at Least One Occurrence of Treatment-emergent Renal Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of Participants With Treatment-emergent Acute Kidney Injury (AKI)
Endpoint domain: Adverse events/effects
Primary endpoint: Plasmatic profiles of hormones and neuropeptides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Colonization rate with multiresistant (MDR) bacteria in hospitalized patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Colonization rate with multiresistant (MDR) bacteria in healthy humans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants With Symptomatic Recurrent Venous Thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Participants Who Died as a Result of VTE
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With No Change or Extension of Thrombotic Burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: maximum biting force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Arm Motor Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Early detection of pancreatic cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Instances of unprotected anal intercourse
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in the State-Trait Anxiety Inventory (STAI) Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Subjects Achieving ACR 20 Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Relative decrease in esophageal time crossed in pH4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: bispectral index (BIS) monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anatomical and functional recurrence of hiatal hernia and GERD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in respiratory system impedance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of yearly growth velocity from baseline to 26 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total propofol requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RFS assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Help Seeking Intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of patient acceptance and completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Gain in papillary height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to chronic TMJMD
Endpoint domain: Mortality/survival
Primary endpoint: Behavioral Changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants With Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non invasive respiratory support (NRS) failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: joint protection behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants With Clinical Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMV Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Anterior Gingival Exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovulation Incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Progesterone Concentrations >16 Nmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Breakthrough Bleeding and/or Spotting
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of dose-limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Imaging quality of skin tumor formations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in fractional iron absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients reporting at least one Adverse Drug Event
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of observed local reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of observed system reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of AEs associated with the vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Audiometric measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Pregnancy Rates
Endpoint domain: Mortality/survival
Primary endpoint: Percent change in osteoclast circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes